WO2007107151A3 - Diagnostisches testsystem zum simultanen quantitativen nachweis von hiv1 und hiv2 antikörpern und/oder hiv antigenen in humanem probenmaterial - Google Patents

Diagnostisches testsystem zum simultanen quantitativen nachweis von hiv1 und hiv2 antikörpern und/oder hiv antigenen in humanem probenmaterial Download PDF

Info

Publication number
WO2007107151A3
WO2007107151A3 PCT/DE2007/000504 DE2007000504W WO2007107151A3 WO 2007107151 A3 WO2007107151 A3 WO 2007107151A3 DE 2007000504 W DE2007000504 W DE 2007000504W WO 2007107151 A3 WO2007107151 A3 WO 2007107151A3
Authority
WO
WIPO (PCT)
Prior art keywords
hiv1
simultaneous
test system
sample material
hiv2
Prior art date
Application number
PCT/DE2007/000504
Other languages
English (en)
French (fr)
Other versions
WO2007107151A2 (de
Inventor
Gerhard Hermann
Christian Popp
Original Assignee
Inst Virion Serion Gmbh
Gerhard Hermann
Christian Popp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Virion Serion Gmbh, Gerhard Hermann, Christian Popp filed Critical Inst Virion Serion Gmbh
Publication of WO2007107151A2 publication Critical patent/WO2007107151A2/de
Publication of WO2007107151A3 publication Critical patent/WO2007107151A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Das Testsystem zum simultanen, quantitativen Nachweis von HIV1 und HIV2 Antikörpern und/ oder HIV Antigenen in humanem Probenmaterial ist dadurch gekennzeichnet ist, daß es als Sondenmoleküle wenigstens (a) HIV1-gp120 oder HIV1-gp41 und (b) HIV2-gp105 oder HIV2-gp36 und (c) HIV1-17 oder HIV1-p32/Integrase oder HIV1-p24 aufweist, und dass diese Sondenmoleküle an Trägerpartikel gekoppelt sind, die einzeln oder gruppenweise durch ihre Partikelgröße und/oder Fluoreszenzfarbstoffmarkierung unterscheidbar charakterisiert sind, und wobei jede Partikelpopulation mit einer anderen Art Sondenmoleküle beladen ist.
PCT/DE2007/000504 2006-03-18 2007-03-16 Diagnostisches testsystem zum simultanen quantitativen nachweis von hiv1 und hiv2 antikörpern und/oder hiv antigenen in humanem probenmaterial WO2007107151A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006012885.0 2006-03-18
DE200610012885 DE102006012885A1 (de) 2006-03-18 2006-03-18 Diagnostisches Testsystem zum simultanen, quantitativen Nachweis von HIV1 und HIV2 Antikörpern und/oder HIV Antigenen in humanem Probenmaterial

Publications (2)

Publication Number Publication Date
WO2007107151A2 WO2007107151A2 (de) 2007-09-27
WO2007107151A3 true WO2007107151A3 (de) 2007-11-29

Family

ID=38356049

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2007/000504 WO2007107151A2 (de) 2006-03-18 2007-03-16 Diagnostisches testsystem zum simultanen quantitativen nachweis von hiv1 und hiv2 antikörpern und/oder hiv antigenen in humanem probenmaterial

Country Status (2)

Country Link
DE (1) DE102006012885A1 (de)
WO (1) WO2007107151A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4895727B2 (ja) * 2006-08-28 2012-03-14 シスメックス株式会社 抗ｈｉｖ抗体検出試薬、試薬キット、試薬の製造方法、及び抗ｈｉｖ抗体の検出方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996027012A1 (en) * 1995-03-02 1996-09-06 Akzo Nobel N.V. Specific hiv-1 group o antigens
WO2004092724A2 (en) * 2003-04-11 2004-10-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
WO2006024466A2 (de) * 2004-08-27 2006-03-09 Institut Virion/Serion Gmbh Testvorrichtung für die in vitro diagnostik von multianalyt-tests und deren verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3322373C2 (de) * 1983-05-19 1986-12-04 Ioannis Dr. 3000 Hannover Tripatzis Testmittel und Verfahren zum Nachweis von Antigenen und/oder Antikörpern
DE3639279C3 (de) * 1986-10-24 1996-06-20 Behringwerke Ag Verfahren zur quantitativen Bestimmung von Antikörpern oder Antigenen nach der ELISA-Methode durch photometrische Auswertung
ATE128716T1 (de) * 1987-11-24 1995-10-15 Abbott Lab Hiv-peptide und methoden für den nachweis von hiv.
ATE171543T1 (de) * 1991-07-16 1998-10-15 Transmed Biotech Inc Verfahren und zusammensetzungen für die gleichzeitige analyse einer vielzahl von analyten
DE4228787A1 (de) * 1992-08-29 1994-03-03 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate
US20030008410A1 (en) * 1995-03-13 2003-01-09 Hechinger Mark K. Immunoassay apparatus, kit and methods
US6846905B2 (en) * 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US5922533A (en) * 1997-08-15 1999-07-13 Abbott Laboratories Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
US6656706B2 (en) * 1999-12-23 2003-12-02 The United States Of America As Represented By The Department Of Health And Human Services Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996027012A1 (en) * 1995-03-02 1996-09-06 Akzo Nobel N.V. Specific hiv-1 group o antigens
WO2004092724A2 (en) * 2003-04-11 2004-10-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
WO2006024466A2 (de) * 2004-08-27 2006-03-09 Institut Virion/Serion Gmbh Testvorrichtung für die in vitro diagnostik von multianalyt-tests und deren verwendung

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BELLISARIO R ET AL: "Simultaneous measurement of antibodies to three HIV-1 antigens in newborn dried blood-spot specimens using a multiplexed microsphere-based immunoassay.", EARLY HUMAN DEVELOPMENT AUG 2001, vol. 64, no. 1, August 2001 (2001-08-01), pages 21 - 25, XP002448036, ISSN: 0378-3782 *
BRUST S ET AL: "Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test.", JOURNAL OF VIROLOGICAL METHODS NOV 2000, vol. 90, no. 2, November 2000 (2000-11-01), pages 153 - 165, XP002448037, ISSN: 0166-0934 *
MODROW S ET AL: "CARRIER BOUND SYNTHETIC OLIGOPEPTIDES IN ELISA TEST SYSTEMS FOR DISTINCTION BETWEEN HIV-1 AND HIV-2 INFECTION", JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, RAVEN PRESS, NEW YORK, US, vol. 2, no. 2, 1 April 1989 (1989-04-01), pages 141 - 148, XP000578021 *
PROBST M C O ET AL: "Bead-based multiplex analysis. BEAD-BASIERTE MULTIPLEXANALYSE", LABORATORIUMSMEDIZIN - JOURNAL OF LABORATORY MEDICINE, BLACKWELL-WISS.-VERLAG, BERLIN, DE, vol. 27, no. 5-6, June 2003 (2003-06-01), pages 182 - 187, XP002342506, ISSN: 0342-3026 *
SCHMIDT B L: "[Detection of HIV infection by serologic procedures]", ZEITSCHRIFT FÜR HAUTKRANKHEITEN JUL 1990, vol. 65, no. 7, July 1990 (1990-07-01), pages 633 - 634 , 637, XP008082744, ISSN: 0301-0481 *
WIRLEITNER B ET AL: "Neopterin in HIV-1 infection", MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, vol. 42, no. 2, February 2005 (2005-02-01), pages 183 - 194, XP004602276, ISSN: 0161-5890 *

Also Published As

Publication number Publication date
WO2007107151A2 (de) 2007-09-27
DE102006012885A1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
US20220341921A1 (en) General Detection and Isolation of Specific Cells by Binding of Labeled Molecules
Pollara et al. High‐throughput quantitative analysis of HIV‐1 and SIV‐specific ADCC‐mediating antibody responses
Lien et al. Rapid detection of influenza A virus infection utilizing an immunomagnetic bead-based microfluidic system
JP2015144617A5 (de)
Navare et al. Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation
JP2016515823A5 (de)
CN102388145A (zh) 用于对单个细胞所具有的细胞毒性进行评价的组合物以及方法
NZ701380A (en) Multiplex immuno screening assay
WO2008048300A3 (en) Pathogen detection biosensor
WO2008147382A8 (en) Integrated microfluidic assay devices and methods
WO2008008785A3 (en) Ultra-sensitive detection of analytes
EP2194380A3 (de) Nachweis eines Zielantigens ungeachtet der An- oder Abwesenheit eines entsprechenden therapeutischen Antikörpers
Seo et al. Highly sensitive detection of a bio-threat pathogen by gold nanoparticle-based oligonucleotide-linked immunosorbent assay
Burton et al. The memory B cell response to influenza vaccination is impaired in older persons
CN101622364A (zh) 监测hiv感染的方法
WO2003095968A3 (fr) Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectueux
Poteet et al. Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV
CN104830996B (zh) 一种基于抗体磁珠捕获的流感病毒检测前处理方法
Ma et al. A multiple-target simultaneous detection method for immunosorbent assay and immunospot assay
JP2016080565A (ja) エボラウイルスのラマン分光検出方法及びエボラウイルス抗体固相化基板
WO2007107151A3 (de) Diagnostisches testsystem zum simultanen quantitativen nachweis von hiv1 und hiv2 antikörpern und/oder hiv antigenen in humanem probenmaterial
Wang et al. Novel DNA sensor system for highly sensitive and quantitative retrovirus detection using virus encoded integrase as a biomarker
CN103221824A (zh) 用于在具有低特异性抗体水平的受试者体内检测感染的方法和试剂盒
WO2023007793A1 (ja) 細胞試料調製試薬
Kaysheva et al. Immuno-MALDI MS dataset for improved detection of HCVcoreAg in sera

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07722064

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07722064

Country of ref document: EP

Kind code of ref document: A2